- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 40/31 - Chimeric antigen receptors [CAR]
Patent holdings for IPC class A61K 40/31
Total number of patents in this class: 1193
10-year publication summary
|
0
|
0
|
1
|
4
|
15
|
48
|
58
|
25
|
20
|
601
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Trustees of the University of Pennsylvania | 4368 |
39 |
| The Regents of the University of California | 20172 |
27 |
| Board of Regents, The University of Texas System | 5898 |
24 |
| Kite Pharma, Inc. | 408 |
22 |
| Memorial Sloan-Kettering Cancer Center | 1965 |
22 |
| Janssen Biotech, Inc. | 1568 |
20 |
| City of Hope | 1003 |
18 |
| Juno Therapeutics, Inc. | 446 |
18 |
| Allogene Therapeutics, Inc. | 153 |
18 |
| Novartis AG | 10686 |
15 |
| The Board of Trustees of the Leland Stanford Junior University | 6500 |
15 |
| Autolus Limited | 257 |
15 |
| Sloan-Kettering Institute for Cancer Research | 532 |
14 |
| Memorial Hospital for Cancer and Allied Diseases | 311 |
14 |
| The General Hospital Corporation | 4784 |
13 |
| Dana-Farber Cancer Institute, Inc. | 2604 |
13 |
| FATE Therapeutics, Inc. | 209 |
11 |
| Regeneron Pharmaceuticals, Inc. | 4364 |
11 |
| Sana Biotechnology, Inc. | 159 |
11 |
| CRISPR Therapeutics AG | 372 |
10 |
| Other owners | 843 |